This interaction alters the expression of miR-34a and miR-17–5p and modulates MICA//MICB (MHC class I-related chain A and B), PDL1 (programmed death ligand-1), and B7-H4 (member of B7 family) expression on triple-negative breast cancer cells [68]. Here, MICB is linked to triple-negative breast carcinoma.